$XNET

Xunlei Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2025

SHENZHEN, China, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- Xunlei Limited ( "Xunlei" or the "Company" ) ( Nasdaq: XNET ) , a leading technology company providing distributed cloud services in China, today announced its unaudited financial results for the third quarter ended September 30, 2025.

Original reporting
GlobeNewswire · Xunlei Limited
Published Nov 13, 2025, 10:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 13, 2025, 10:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Xunlei Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2025 — source image
Decision brief

The 30-second read

$XNETBullishMed
01

Why it matters

Strong Q3 results reinforce the company's growth trajectory and market position.

02

Market read

The news is highly relevant for investors interested in Chinese technology and cloud sectors.

03

What to watch

Regulatory risks in China or macroeconomic factors could offset earnings benefits.

Timing: Immediate, as earnings results are recent and can influence short-term trading decisions.

Background

Xunlei Limited is a leading provider of distributed cloud services in China, with recent focus on expanding cloud infrastructure.

Company-level read

Ticker impact

$XNETBullishHigh confidence
Context

Primary focus of the news; company reports Q3 financial results.

Expected impact

Moderate upward movement in the short term, potential for sustained growth if results are confirmed.

Evidence & confidence

Strong financial performance and positive market sentiment support an optimistic outlook.

Market effects

Positive earnings may boost investor confidence in the cloud and technology sector in China.

Potential uplift in regional tech stocks; limited impact on broader regional markets.

Limited, as Xunlei's operations are primarily China-focused.

Counterpoint

The positive earnings may already be priced in; potential for profit-taking leading to short-term correction.

Key entities

  • Xunlei Limited

    Leading Chinese cloud service provider.

Related articles

$XNETMedAI 8/10

Xunlei (XNET) Q2 2026 Earnings Call Transcript

Xunlei (XNET) reported Q2 2026 results in an earnings call transcript. Total revenue rose to $102.7 million, up 38.9% year over year, driven by subscription revenue of $44.5 million (+22.6%) and overseas audio live streaming revenue of $58.2 million (+54.8%). Gross margin fell to 55.8% from 63%. The company announced a $20 million share repurchase program.

$XNETMedAI 8/10

Xunlei Limited: Xunlei Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2026

Xunlei Limited (Nasdaq: XNET) reported unaudited Q2 2026 results for the quarter ended June 30, 2026. Total revenues were $102.7M (+38.9% YoY), with subscription $44.5M (+22.6%) and live-streaming/other $58.2M (+54.8%). Gross profit was $57.3M (margin 55.8% vs 63.0%). Net loss from continuing ops was $218.5M ($3.43 loss per ADS); non-GAAP net loss was $2.1M. The company also announced a new share repurchase program.

$XNETMedAI 9/10

Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2026

Xunlei Limited (Nasdaq: XNET) reported unaudited Q1 2026 results for the quarter ended March 31, 2026. Total revenue rose 54.1% YoY to $98.6m, driven by subscription ($45.0m, +26.2%) and overseas audio live-streaming ($53.6m, +89.3%). Gross profit increased to $57.7m, but margin fell to 58.5%. Net loss from continuing operations was $192.4m; non-GAAP net income was $4.1m.

$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.